TNDM R&D to Revenue
Tandem Diabetes Care Inc · R&D to Revenue
TNDM R&D to Revenue
Latest reported17.23%period ending
TNDM FY R&D/Revenue (0.00% → 17.23%)
Latest values, visible window
High-resolution chart · PNG
TNDM r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 17.2297% | |
| 21.1526% | |
| 33.2234% | |
| 21.2368% | |
| 13.0982% | |
| 12.7446% | |
| 12.4754% | |
| 15.8958% | |
| 19.2015% | |
| 22.3258% | |
| 23.2848% | |
| 31.7586% | |
| 38.1954% | |
| 364.0456% | |
| 0% |